A landmark multi-institution collaboration has found no reproducible lasting behavioural changes in mice 24 hours after a ...
Six scientists and industry experts discuss the challenges of automating drug discovery, from improving screening reliability ...
Promising compounds don’t always engage their targets in living cells. At ELRIG Drug Discovery 2026, Dr Joshua Sopp of Promega discusses why earlier cellular testing matters and how BRETSA could help ...
A new study has mapped previously unknown RNA-protein interactions across the SARS-CoV-2 genome, identifying conserved sites ...
What if researchers could design therapeutic antibodies instead of relying on screening millions of candidates? Generative AI ...
How reliable are AI virtual cells compared with experimental models? We examine what each can predict or measure, the ...
How can multiomics help researchers identify more promising drug targets? Dr Shi-qi An explores how combining molecular data ...
A new review of primary biliary cholangitis reveals how interactions between bile duct epithelial cells and immune ...
Researchers have designed an antifungal compound that targets a molecular feature unique to fungi, showing activity against ...
Two cancer drugs appeared almost identical in conventional screening, but a new 3D Cell Painting method exposed striking ...
A bispecific antibody targeting CCR8 and CD3 has demonstrated the ability to deplete immunosuppressive regulatory T cells and ...
Could targeting SRC-3 in regulatory T cells help overcome tumour immunosuppression? Researchers explain how this approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results